Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Loss-of-function mutations in the Prkar1a gene are linked to Carney complex disorder.
• Prkar1a defects are believed to hyperactivate PKA signaling, promoting neoplastic transformation.
• Prkar1a is considered a tumor suppressor due to its role in regulating cell growth.

Purpose of the Study:

• To investigate the role of Prkar1a in apoptosis and tumor development.
• To elucidate the mechanisms by which Prkar1a loss affects cell viability and tumorigenesis.
• To understand the interplay between Prkar1a, apoptosis regulators, and tumor progression.

Main Methods:

• Utilized genetically modified mice with Prkar1a gene alterations.
• Analyzed transcriptional activation of Bcl-2 family members.
• Assessed fibroblast colony formation and tumor growth in immune-deficient mice.
• Examined tumor development in a skin cancer model with combined Prkar1a and Bim gene loss.

Main Results:

• Prkar1a loss induced transcriptional activation of pro-apoptotic Bcl-2 family members, leading to cell death.
• Combined loss of Bim and Prkar1a enhanced fibroblast colony formation and promoted tumor growth.
• Systemic Prkar1a deletion caused cachexia, muscle loss, macrophage activation, and increased lipolysis.
• Loss of a single Prkar1a allele did not enhance skin cancer development, but combined loss with Bim delayed tumorigenesis, associated with PUMA and NOXA upregulation.

Conclusions:

• Prkar1a loss can induce apoptosis, acting as a tumor suppressor.
• Tumorigenesis promotion by Prkar1a loss requires counteraction of Prkar1a-mediated apoptosis.
• The findings highlight a complex regulatory role of Prkar1a in cancer, dependent on apoptotic pathways.